Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
2005-7-25
pubmed:abstractText
flake (flk), an N-ethyl-N-nitrosourea-induced recessive germ line mutation of C57BL/6 mice, impairs the clearance of skin infections by Streptococcus pyogenes and Staphylococcus aureus, gram-positive pathogens that elicit innate immune responses by activating Toll-like receptor 2 (TLR2). Positional cloning and sequencing revealed that flk is a novel allele of the stearoyl coenzyme A desaturase 1 gene (Scd1). flake homozygotes show reduced sebum production and are unable to synthesize the monounsaturated fatty acids (MUFA) palmitoleate (C(16:1)) and oleate (C(18:1)), both of which are bactericidal against gram-positive (but not gram-negative) organisms in vitro. However, intradermal MUFA administration to S. aureus-infected mice partially rescues the flake phenotype, which indicates that an additional component of the sebum may be required to improve bacterial clearance. In normal mice, transcription of Scd1-a gene with numerous NF-kappaB elements in its promoter--is strongly and specifically induced by TLR2 signaling. Similarly, the SCD1 gene is induced by TLR2 signaling in a human sebocyte cell line. These observations reveal the existence of a regulated, lipid-based antimicrobial effector pathway in mammals and suggest new approaches to the treatment or prevention of infections with gram-positive bacteria.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/16040962-10545940, http://linkedlifedata.com/resource/pubmed/commentcorrection/16040962-10594745, http://linkedlifedata.com/resource/pubmed/commentcorrection/16040962-10623793, http://linkedlifedata.com/resource/pubmed/commentcorrection/16040962-10854228, http://linkedlifedata.com/resource/pubmed/commentcorrection/16040962-11290821, http://linkedlifedata.com/resource/pubmed/commentcorrection/16040962-11533264, http://linkedlifedata.com/resource/pubmed/commentcorrection/16040962-11719807, http://linkedlifedata.com/resource/pubmed/commentcorrection/16040962-11807545, http://linkedlifedata.com/resource/pubmed/commentcorrection/16040962-12114623, http://linkedlifedata.com/resource/pubmed/commentcorrection/16040962-12177411, http://linkedlifedata.com/resource/pubmed/commentcorrection/16040962-12374882, http://linkedlifedata.com/resource/pubmed/commentcorrection/16040962-12558847, http://linkedlifedata.com/resource/pubmed/commentcorrection/16040962-12614458, http://linkedlifedata.com/resource/pubmed/commentcorrection/16040962-12646202, http://linkedlifedata.com/resource/pubmed/commentcorrection/16040962-12677098, http://linkedlifedata.com/resource/pubmed/commentcorrection/16040962-12877635, http://linkedlifedata.com/resource/pubmed/commentcorrection/16040962-12935356, http://linkedlifedata.com/resource/pubmed/commentcorrection/16040962-12936968, http://linkedlifedata.com/resource/pubmed/commentcorrection/16040962-12960377, http://linkedlifedata.com/resource/pubmed/commentcorrection/16040962-14632104, http://linkedlifedata.com/resource/pubmed/commentcorrection/16040962-14654089, http://linkedlifedata.com/resource/pubmed/commentcorrection/16040962-14660555, http://linkedlifedata.com/resource/pubmed/commentcorrection/16040962-1612733, http://linkedlifedata.com/resource/pubmed/commentcorrection/16040962-2943823, http://linkedlifedata.com/resource/pubmed/commentcorrection/16040962-3341800, http://linkedlifedata.com/resource/pubmed/commentcorrection/16040962-3710582, http://linkedlifedata.com/resource/pubmed/commentcorrection/16040962-484550, http://linkedlifedata.com/resource/pubmed/commentcorrection/16040962-7480063, http://linkedlifedata.com/resource/pubmed/commentcorrection/16040962-7545057, http://linkedlifedata.com/resource/pubmed/commentcorrection/16040962-7719068
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Aug
pubmed:issn
0019-9567
pubmed:author
pubmed:issnType
Print
pubmed:volume
73
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4512-21
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:16040962-Animals, pubmed-meshheading:16040962-Anti-Bacterial Agents, pubmed-meshheading:16040962-Chromosome Mapping, pubmed-meshheading:16040962-Eye Diseases, pubmed-meshheading:16040962-Fatty Acids, Monounsaturated, pubmed-meshheading:16040962-Likelihood Functions, pubmed-meshheading:16040962-Lod Score, pubmed-meshheading:16040962-Mice, pubmed-meshheading:16040962-Mice, Inbred C57BL, pubmed-meshheading:16040962-Oleic Acid, pubmed-meshheading:16040962-Receptors, Immunologic, pubmed-meshheading:16040962-Sequence Analysis, DNA, pubmed-meshheading:16040962-Skin, pubmed-meshheading:16040962-Staphylococcal Skin Infections, pubmed-meshheading:16040962-Stearoyl-CoA Desaturase, pubmed-meshheading:16040962-Streptococcus pyogenes, pubmed-meshheading:16040962-Time Factors, pubmed-meshheading:16040962-Toll-Like Receptor 2
pubmed:year
2005
pubmed:articleTitle
A toll-like receptor 2-responsive lipid effector pathway protects mammals against skin infections with gram-positive bacteria.
pubmed:affiliation
Department of Immunology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, CA 92037, USA.
pubmed:publicationType
Journal Article
More...